Jeffrey S. Hatfield
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jeffrey S. Hatfield
Jeffrey S. Hatfield was last confirmed as Board Member at Viridian Therapeutics, Inc.\DE (VRDN) in a filing dated April 10, 2020. Jeffrey S. Hatfield was last confirmed as Board Member at aTYR PHARMA INC (ATYR) in a filing dated March 24, 2021. Jeffrey S. Hatfield was last confirmed as Board Member at Vir Biotechnology, Inc. (VIR) in a filing dated April 17, 2025.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2020-01-01–2025-04-17
Last confirmed by a filing; no departure on record
-
Start not stated–2020-04-10
Last confirmed by a filing; no departure on record
-
Start not stated–2021-03-24
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
No call appearances or filed executive changes recorded yet.